Cannabis Capital Corp (CBCA) is a United States company actively pursuing investment opportunities in the rapidly growing global Medical Cannabis Industry. CBCA invests in companies positioned to make a significant impact within the global medical and legal marijuana markets.
These early stage investments provide emerging companies with access to larger capital sums to help elevate their status from start-ups to a mature and durable brand leader. Recent legislative changes around the world are creating compelling investment opportunities in which CBCA is positioned to be an identifier of and an early stage investor in promising companies in the industry.
CBCA Detailed Quote
|Day's Range:||2.41 - 2.41|
|52wk Range:||0.01 - 9.49|
CBCA Recent Headlines
- Crown Baus Capital Corp. Acquires 100-Acre Investment Participation in Cannabis Science's California and Nevada Property and Drug Development Projects 02/17/2017 01:41 PM[Marketwired] - Crown Baus Capital Corp. announces the Company acquires 100-acre investment participation in the Cannabis Science, Inc. Property and Drug Development Projects spread across California and Nevada. The agreement ...
- Crown Baus Team Negotiates Investment Opportunity with Cannabis Science (CBIS) for Stake in California Property Development Projects and the Nevada Cannabinoid Drug Production Facilities in Douglas County, Nevada 02/07/2017 02:03 PM[Marketwired] - Crown Baus Capital Corp. , is a global acquisition-based conglomerate looking to aggressively capitalize on its key industry strengths. Mr. Raymond C. Dabney, Crown Baus President & CEO, is pleased to ...
- CROWN BAUS CAPITAL CORP. Files SEC form 8-K, Change in Directors or Principal Officers 09/20/2016 05:28 PM